First year for Abrdn China was tough, but now the recovery is on
Portfolio managers Nicholas Yeo and Elizabeth Kwik’s Abrdn China trust faced a tough debut year. They have regrouped, though, and are investing in new opportunities.
Investment company news brought to you by Citywire Financial Publishers Limited and Quoted Data by Marten & Co.
Home Reit puts itself up for sale and receives bid approach from Bluestar
Real estate investment trust says it is considering all strategic options after the resignation of its brokers, a rent strike by tenants and a probe into its accounts. The potential bidder is run by a former employee of its fund manager.
‘Saints’ comes marching in after a distressing 2022
Scottish American is the Baillie Gifford investment trust that beat its benchmark last year. The £900m global equity income fund nears its 150th anniversary in good shape.
Home Reit receives bid approach from Bluestar
Suspended homeless accommodation provider struggling with a rent strike and allegations of financial wrongdoing has been approached by the property debt investor over a possible cash bid.
Whitestone says sorry after Throgmorton thumped in 2022 selloff
Dan Whitestone of BlackRock Throgmorton apologises for not de-risking the UK smaller companies trust earlier. However, he insists his growth stocks are poised for recovery.
NatWest’s £144m swoop for Cushon plumps Augmentum’s reputation
High street bank's acquisition of workplace pension provider nets 46% gain for Augmentum, a backer of early-stage financial services disrupters whose shares are in urgent need of an uplift themselves on a 30% discount.
Shires Income held talks with Abrdn Smaller Co’s
Shires Income positions itself as a key player in Abrdn Smaller Companies Income's search for a merger partner, disclosing recent talks with its stable mate.
Yakas and Kyprianou retire from Polar Capital Global Financials
Co-manager John Yakas and chairman Robert Lyprianou are stepping back from London's only listed financials fund.
David Stevenson: Time for deeply unloved trusts to bite the bullet
It is ‘show-and-tell time’ for many investment companies trading at discounts of more than 20% below net asset value.
James Carthew: Pershing Square on my buy-list after fresh US listing talk
Our columnist considers topping up his position in Pershing Square after Bill Ackman tells investors he is serious about solving the US equity fund’s 35% discount.
Abrdn Smaller Co’s Income looks for merger after 2022 hammering
Shares in £68m portfolio leap after its board launches a strategic review, concluding the trust is too small to have a viable future.
Int’l Biotechnology consults investors after fund group resigns
SV Health, manager of the £300m International Biotechnology Trust, serves 12-month notice, saying it wants to focus on its healthcare venture business.
